20Oct 2023
Utility of palliative prognostic index and neutrophil‐to‐lymphocyte ratio in predicting prognosis of end‐stage squamous cell carcinoma of head and neck

Utility of palliative prognostic index and neutrophil‐to‐lymphocyte ratio in predicting prognosis of end‐stage squamous cell carcinoma of head and neck

In this study on end‐stage head and neck squamous cell carcinoma (HNSCC), 79 patients were analyzed. The study aimed to identify factors influencing prognosis and establish a more effective prognostic index. Patients were categorized based on specific factors and prognostic indicators. Comparisons of overall survival were made between groups starting Best Supportive Care. Moreover, patients with a palliative prognostic index (PPI) ≥6 and neutrophil‐to‐lymphocyte ratio (NLR) ≥10 were contrasted with those having PPI <6 or NLR <10. Results revealed that PPI ≥6 and NLR ≥10 correlated significantly with poorer prognoses (p = 0.01 and p = 0.002, respectively). Median survival for cases with PPI ≥6 and NLR ≥10 was 32 days, while it was 64 days for PPI <6 or NLR <10 (p < 0.001). Therefore, the combination of PPI and NLR serves as a valuable prognostic indicator for predicting the prognosis of patients with end‐stage HNSCC.

  • #ent

Like

Save

Share